Chen Yongshun, Wang Ying, Song Haixia, Wang Jin, Yang Haijun, Xia Yubing, Xue Jianxin, Li Shidong, Chen Ming, Lu You
Division of Thoracic Oncology, West China Hospital, Cancer Center, West China School of Clinical Medicine, Sichuan University, 37, Guoxue Lane, Chengdu, China, 610041,
Tumour Biol. 2014 May;35(5):4339-46. doi: 10.1007/s13277-013-1569-2. Epub 2014 Jan 9.
Definitive chemoradiation is a curative treatment option for patients with locoregional esophageal squamous cell carcinoma (ESCC) who are not suitable for surgical resection, but many tend to develop local recurrence. The purpose of the study was to investigate factors affecting local recurrence of the tumor. Seventy-two patients with stage II-III thoracic ESCC who received definitive concurrent chemoradiation (CRT) and completely responded to the treatment were enrolled into this study. The case patients were 49 patients who recurred locally within 24 months after definitive CRT and 23 patients who did not have a local recurrence within 24 months were considered as controls. We investigated whether dysregulation of apoptosis-related genes was associated with early tumor recurrence. Quantitative real-time polymerase chain reaction showed upregulation of BCLAF1 and downregulation of BAG4, CARD6, IGF1R, and TNF in the tissues of case patients, as compared with controls. Among the patients with recurrent ESCC, those with tumors which exhibited more than twofold upregulated BCLAF1 and more than twofold downregulated BAG4 and TNF had a decreased time interval to local recurrence. Three gene pairs of the downregulated genes showed a significant correlation with local recurrence: BAG4 and CARD6, BAG4 and TNF, CARD6, and TNF. The patients with T3-4 disease and those with tumor >3 cm in length had a trend toward early local recurrence, though the associations were not reached statistical significance. Upregulation of BCLAF1 and downregulation of BAG4 and TNF was independently associated with early local recurrence in multivariate analysis (P < 0.05). This study supports the involvement of apoptosis-related genes in early tumor recurrence after definitive chemoradiation in patients with stage II-III thoracic ESCC.
对于不适合手术切除的局部区域食管鳞状细胞癌(ESCC)患者,确定性放化疗是一种治愈性治疗选择,但许多患者往往会出现局部复发。本研究的目的是调查影响肿瘤局部复发的因素。72例接受确定性同步放化疗(CRT)且对治疗完全缓解的II-III期胸段ESCC患者纳入本研究。病例组为49例在确定性CRT后24个月内局部复发的患者,23例在24个月内未出现局部复发的患者作为对照组。我们调查了凋亡相关基因的失调是否与肿瘤早期复发有关。定量实时聚合酶链反应显示,与对照组相比,病例组患者组织中BCLAF1上调,BAG4、CARD6、IGF1R和TNF下调。在复发性ESCC患者中,肿瘤BCLAF1上调超过两倍且BAG4和TNF下调超过两倍的患者局部复发时间间隔缩短。下调基因的三对基因与局部复发显著相关:BAG4与CARD6、BAG4与TNF、CARD6与TNF。T3-4期疾病患者和肿瘤长度>3 cm的患者有早期局部复发的趋势,但相关性未达到统计学意义。多因素分析中,BCLAF1上调以及BAG4和TNF下调与早期局部复发独立相关(P<0.05)。本研究支持凋亡相关基因参与II-III期胸段ESCC患者确定性放化疗后肿瘤早期复发。